Sfoglia per Autore
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
2022-01-01 Francesca Saluzzo; Luca Riberi; Barbara Messore; Nicola Ivan Loré; Irene Esposito; Elisabetta Bignamini; Virginia De Rose
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases
2022-01-01 Alessandra Ghigo, Alessandra Murabito, Valentina Sala, Anna Rita Pisano, Serena Bertolini, Ambra Gianotti, Emanuela Caci, Alessio Montresor, Aiswarya Premchandar, Flora Pirozzi, Kai Ren, Angela Della Sala, Marco Mergiotti, Wito Richter, Eyleen de Poel, Michaela Matthey, Sara Caldrer, Rosa A Cardone, Federica Civiletti, Andrea Costamagna, Nancy L Quinney, Cosmin Butnarasu, Sonja Visentin, Maria Rosaria Ruggiero, Simona Baroni, Simonetta Geninatti Crich, Damien Ramel, Muriel Laffargue, Carlo G Tocchetti, Renzo Levi, Marco Conti, Xiao-Yun Lu, Paola Melotti, Claudio Sorio, Virginia De Rose, Fabrizio Facchinetti, Vito Fanelli, Daniela Wenzel, Bernd K Fleischmann, Marcus A Mall, Jeffrey Beekman, Carlo Laudanna, Martina Gentzsch, Gergely L Lukacs, Nicoletta Pedemonte, Emilio Hirsch
Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches
2021-01-01 Ghigo A.; Prono G.; Riccardi E.; De Rose V.
Lung immunoglobulin A immunity dysregulation in cystic fibrosis.
2020-01-01 Amandine M. Collin, Marylène Lecocq, Sabrina Noel, Bruno Detry, François M. Carlier, F rank Aboubakar Nana, Caroline Bouzin, Teresinha Leal, Marjorie Vermeersch, Virginia De Rose,L ucile Regard, Clémence Martin, Pierre-Régis Burgel, Delphine Hoton,Stijn Verleden, Antoine Froidure, Charles Pilette, and Sophie Gohy
CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease
2018-01-01 Fernandez Fernandez, Elena; De Santi, Chiara; De Rose, Virginia; Greene, Catherine M
Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
2018-01-01 De Rose, Virginia; Burgel, Pierre-Régis; Gaggar, Amit; Greene, Catherine
Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
2018-01-01 De Rose, Virginia; Molloy, Kevin; Gohy, Sophie; Pilette, Charles; Greene, Catherine M
Genetic deletion and pharmacological inhibition of PI3K γ reduces neutrophilic airway inflammation and lung damage in mice with cystic fibrosis-like lung disease
2015-01-01 Galluzzo, Maria; Ciraolo, Elisa; Lucattelli, Monica; Hoxha, Eriola; Ulrich, Martina; Campa, Carlo Cosimo; Lungarella, Giuseppe; Doring, Gerd; Zhou-Suckow, Zhe; Mall, Marcus; Hirsch, Emilio; De Rose, Virginia
Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD
2013-01-01 Ricciardolo FLM; Sabatini F; Sorbello V; Benedetto S; Defilippi I; Petecchia L; Usai C; Gnemmi I; Balbi B; De Rose V; Ten Hacken NH; Postma DS; Timens W; Di Stefano A.
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate
2013-01-01 Bianchi ML; Colombo C; Assael BM; Dubini A; Lombardo M; Quattrucci S; Bella S; Collura M; Messore B; Raia V; Poli F; Bini R; Albanese CV; De Rose V; Costantini D; Romano G; Pustorino E; Magazzù G; Bertasi S; Lucidi V; Traverso G; Coruzzo A; Grzejdziak AD.
Bradykinin- and lipopolysaccharide-induced bradykinin B(2) receptor expression, interleukin 8 release and "nitrosative stress" in bronchial epithelial cells BEAS-2B: Role for neutrophils.
2012-01-01 Ricciardolo FLM; Sorbello V; Benedetto S; Defilippi I; Sabatini F; Robotti A; van Renswouw DC; Bucca C; Folkerts G; De Rose V.
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.
2011-01-01 Crovella S; Segat L; Amato A; Athanasakis E; Bezzerri V; Braggion C; Casciaro R; Castaldo G; Colombo C; Covone AE; De Rose V; Gagliardini R; Lanzara C; Minicucci L; Morgutti M; Nicolis E; Pardo F; Quattrucci S; Raia V; Ravazzolo R; Seia M; Stanzial V; Termini L; Zazzeron L; Cabrini G; Gasparini P
Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
2010-01-01 Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R; EOLO study group including, De Rose V
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
2010-01-01 Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators including, De Rose V.
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial
2009-01-01 Marc Decramer ; Bartolome Celli; Steven Kesten ; Theodore Lystig ; Sunil Mehra ; Donald P Tashkin; for the UPLIFT investigators; Virginia De Rose
The guinea pig as an animal model for asthma
2008-01-01 Ricciardolo FLM; Nijkamp F; De Rose V; Folkerts G
La semeiotica dell’Apparato Respiratorio
2008-01-01 Messore B; De Rose V
Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease
2008-01-01 Mitola S; Sorbello V; Ponte E; Copreni E; Mascia C; Bardessono M; Goia M; Biasi F; Conese M; Poli G; Bussolino F; De Rose V.
Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis
2008-01-01 Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V.
Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease
2007-01-01 ZHU J ;QIU Y ;VALOBRA M ;QIU S ;MAJUMDAR S ;MATIN D ;DE ROSE V ;JEFFERY PK
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis | 2022 | Francesca Saluzzo; Luca Riberi; Barbara Messore; Nicola Ivan Loré; Irene Esposito; Elisabetta Bignamini; Virginia De Rose | |
| A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases | 2022 | Alessandra Ghigo, Alessandra Murabito, Valentina Sala, Anna Rita Pisano, Serena Bertolini, Ambra Gianotti, Emanuela Caci, Alessio Montresor, Aiswarya Premchandar, Flora Pirozzi, Kai Ren, Angela Della Sala, Marco Mergiotti, Wito Richter, Eyleen de Poel, Michaela Matthey, Sara Caldrer, Rosa A Cardone, Federica Civiletti, Andrea Costamagna, Nancy L Quinney, Cosmin Butnarasu, Sonja Visentin, Maria Rosaria Ruggiero, Simona Baroni, Simonetta Geninatti Crich, Damien Ramel, Muriel Laffargue, Carlo G Tocchetti, Renzo Levi, Marco Conti, Xiao-Yun Lu, Paola Melotti, Claudio Sorio, Virginia De Rose, Fabrizio Facchinetti, Vito Fanelli, Daniela Wenzel, Bernd K Fleischmann, Marcus A Mall, Jeffrey Beekman, Carlo Laudanna, Martina Gentzsch, Gergely L Lukacs, Nicoletta Pedemonte, Emilio Hirsch | |
| Dysfunctional inflammation in cystic fibrosis airways: From mechanisms to novel therapeutic approaches | 2021 | Ghigo A.; Prono G.; Riccardi E.; De Rose V. | |
| Lung immunoglobulin A immunity dysregulation in cystic fibrosis. | 2020 | Amandine M. Collin, Marylène Lecocq, Sabrina Noel, Bruno Detry, François M. Carlier, F rank Aboubakar Nana, Caroline Bouzin, Teresinha Leal, Marjorie Vermeersch, Virginia De Rose,L ucile Regard, Clémence Martin, Pierre-Régis Burgel, Delphine Hoton,Stijn Verleden, Antoine Froidure, Charles Pilette, and Sophie Gohy | |
| CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease | 2018 | Fernandez Fernandez, Elena; De Santi, Chiara; De Rose, Virginia; Greene, Catherine M | |
| Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis | 2018 | De Rose, Virginia; Burgel, Pierre-Régis; Gaggar, Amit; Greene, Catherine | |
| Airway Epithelium Dysfunction in Cystic Fibrosis and COPD | 2018 | De Rose, Virginia; Molloy, Kevin; Gohy, Sophie; Pilette, Charles; Greene, Catherine M | |
| Genetic deletion and pharmacological inhibition of PI3K γ reduces neutrophilic airway inflammation and lung damage in mice with cystic fibrosis-like lung disease | 2015 | Galluzzo, Maria; Ciraolo, Elisa; Lucattelli, Monica; Hoxha, Eriola; Ulrich, Martina; Campa, Carlo Cosimo; Lungarella, Giuseppe; Doring, Gerd; Zhou-Suckow, Zhe; Mall, Marcus; Hirsch, Emilio; De Rose, Virginia | |
| Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD | 2013 | Ricciardolo FLM; Sabatini F; Sorbello V; Benedetto S; Defilippi I; Petecchia L; Usai C; Gnemmi I; Balbi B; De Rose V; Ten Hacken NH; Postma DS; Timens W; Di Stefano A. | |
| Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate | 2013 | Bianchi ML; Colombo C; Assael BM; Dubini A; Lombardo M; Quattrucci S; Bella S; Collura M; Messore B; Raia V; Poli F; Bini R; Albanese CV; De Rose V; Costantini D; Romano G; Pustorino E; Magazzù G; Bertasi S; Lucidi V; Traverso G; Coruzzo A; Grzejdziak AD. | |
| Bradykinin- and lipopolysaccharide-induced bradykinin B(2) receptor expression, interleukin 8 release and "nitrosative stress" in bronchial epithelial cells BEAS-2B: Role for neutrophils. | 2012 | Ricciardolo FLM; Sorbello V; Benedetto S; Defilippi I; Sabatini F; Robotti A; van Renswouw DC; Bucca C; Folkerts G; De Rose V. | |
| A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. | 2011 | Crovella S; Segat L; Amato A; Athanasakis E; Bezzerri V; Braggion C; Casciaro R; Castaldo G; Colombo C; Covone AE; De Rose V; Gagliardini R; Lanzara C; Minicucci L; Morgutti M; Nicolis E; Pardo F; Quattrucci S; Raia V; Ravazzolo R; Seia M; Stanzial V; Termini L; Zazzeron L; Cabrini G; Gasparini P | |
| Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. | 2010 | Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R; EOLO study group including, De Rose V | |
| Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. | 2010 | Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators including, De Rose V. | |
| Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial | 2009 | Marc Decramer ; Bartolome Celli; Steven Kesten ; Theodore Lystig ; Sunil Mehra ; Donald P Tashkin; for the UPLIFT investigators; Virginia De Rose | |
| The guinea pig as an animal model for asthma | 2008 | Ricciardolo FLM; Nijkamp F; De Rose V; Folkerts G | |
| La semeiotica dell’Apparato Respiratorio | 2008 | Messore B; De Rose V | |
| Tumor necrosis factor-alpha in airway secretions from cystic fibrosis patients upregulate endothelial adhesion molecules and induce airway epithelial cell apoptosis: implications for cystic fibrosis lung disease | 2008 | Mitola S; Sorbello V; Ponte E; Copreni E; Mascia C; Bardessono M; Goia M; Biasi F; Conese M; Poli G; Bussolino F; De Rose V. | |
| Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis | 2008 | Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V. | |
| Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease | 2007 | ZHU J ;QIU Y ;VALOBRA M ;QIU S ;MAJUMDAR S ;MATIN D ;DE ROSE V ;JEFFERY PK |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile